GIC Re Rs 3,088 Crore OFS: Should Retail Investors Participate?

The General Insurance Corporation of India (GIC Re) is back in the spotlight as its ₹3,088 crore Offer for Sale (OFS) opens for retail investors on Wednesday, June 17. Following a highly successful day for institutional bidders, the market is now closely watching whether individual investors should seize this opportunity.

Understanding the OFS Structure and Demand

The government’s disinvestment plan aims to sell up to a 5% equity stake in the state-run reinsurer. The base offer consists of 3.51 crore shares (a 2% stake), with the government exercising the "green shoe" option to sell an additional 5.26 crore shares (a 3% stake). This brings the total offering to 8.77 crore shares.

The floor price for the OFS is set at ₹352 per share, which represents a 2% discount to the stock’s previous closing price. Early indicators suggest strong institutional interest; on the first day of bidding for non-retail investors, the issue was already oversubscribed 3.72 times.

Analyst Caution: Profitability and Sector Headwinds

Despite the robust demand from institutions, market experts are urging retail investors to exercise caution. Analysts from SBI Securities have advised skipping the subscription, citing fundamental concerns regarding GIC Re's operational efficiency.

A primary concern is the company's "combined ratio," which stood at 106% for FY26. While this is an improvement from 109% in FY23, a ratio above 100% indicates that the company is paying out more in claims and expenses than it is earning in premiums. Consequently, GIC Re is heavily reliant on its massive investment portfolio—valued at approximately ₹1.5 lakh crore as of FY26—to drive its bottom-line profits. Furthermore, the reinsurance industry is currently battling intense pricing pressure and heightened competition.

Stock Performance and Valuation

The market reaction to the OFS has been tepid for the stock itself. GIC Re shares tumbled over 7% on Tuesday following the announcement, contributing to a broader decline of 6% over the past week. The stock has struggled in 2026, down nearly 6% year-to-date.

From a valuation perspective, the business is trading at an estimated FY26 Price to Book (P/B) value of 1.2x (excluding fair value changes), with a Return on Equity (RoE) of 16.4%. While the long-term trajectory has been positive—with an 88% gain over three years—the immediate term remains clouded by the company's struggle to deliver consistent operational profits.

Key Takeaways